Enhanced TCR Therapy for MM: Preliminary Phase I/II data

Preliminary data from 13 evaluable MM patients in a single-arm, open-label, U.S. Phase I/II trial showed that enhanced TCR therapy given in conjunction with autologous stem cell transplantation led to...